Specific expression of reporter gene FTH1 driven by progression elevated gene-3 promoter in malignant transformation of rat mesenchymal stem cells and its detection by in vitro magnetic resonance imaging
Basic Medicine|更新时间:2026-01-09
|
Specific expression of reporter gene FTH1 driven by progression elevated gene-3 promoter in malignant transformation of rat mesenchymal stem cells and its detection by in vitro magnetic resonance imaging
Journal of Third Military Medical UniversityVol. 41, Issue 12, Pages: 1117-1124(2019)
Jun SUN, Jinhua CAI, Yong QIN, et al. Specific expression of reporter gene FTH1 driven by progression elevated gene-3 promoter in malignant transformation of rat mesenchymal stem cells and its detection by in vitro magnetic resonance imaging[J]. Journal of Third Military Medical University, 2019, 41(12): 1117-1124.
DOI:
Jun SUN, Jinhua CAI, Yong QIN, et al. Specific expression of reporter gene FTH1 driven by progression elevated gene-3 promoter in malignant transformation of rat mesenchymal stem cells and its detection by in vitro magnetic resonance imaging[J]. Journal of Third Military Medical University, 2019, 41(12): 1117-1124. DOI: 10.16016/j.1000-5404.201812082.
Specific expression of reporter gene FTH1 driven by progression elevated gene-3 promoter in malignant transformation of rat mesenchymal stem cells and its detection by in vitro magnetic resonance imaging
摘要
目的
2
探讨利用肿瘤特异性启动子PEG3驱动MRI报告基因铁蛋白重链(ferritin heavy chain 1
To explore the feasibility of using progression elevated gene-3 (PEG3) promoter
a tumor-specific promoter
to drive the specific expression of the reporter gene ferritin heavy chain 1 (FTH1) and the detection of FTH1 expression using
in vitro
magnetic resonance imaging (MRI) in bone marrow mesenchymal stem cells (MSCs) after malignant transformation.
Methods
2
A viral vector carrying the reporter gene FTH1 driven by PEG3 promoter was transfected into rat MSCs to obtain MSCs-PEG3-FTH1 cells
and the MSCs transfected with a viral vector carrying FTH1 driven by the CMV promoter (MSCs-CMV-FTH1 cells) and the MSCs without transfection served as the controls. The non-transfected MSCs
MSCs-PEG3-FTH1 cells
and MSCs-CMV-FTH1 cells were indirectly co-cultured with rat glioma C6 cells for 2 weeks to induce their malignant transformation (TMSCs
TMSCs-PEG3-FTH1 and TMSC-PEG3-FTH1 cells
respectively). The morphology
migration and proliferation
and the cell surface antigens CD29
CD34
CD45 and CD90 of the transformed cells were observed and analyzed
and their capacity of subcutaneous tumor formation was evaluated in nude mice. Western blotting
Prussian blue staining
transmission electron microscopy
and
in vitro
MRI were used to detect the
changes in the expression of FTH1 gene in the cells after the transformation.
Results
2
Compared with MSCs
most of TMSCs were small in size with a spindle-like morphology and showed strong proliferation and migration abilities with increased expression of CD34 and CD45
decreased expression of CD90 (
P
<
0.05)
and an ability of subcutaneous tumor formation in nude mice. Western blotting showed that FTH1 protein was not expressed or expressed at low levels in MSCs
MSCs-PEG3-FTH1 cells and TMSCs
while high FTH1 expression was detected in MSCs-CMV-FTH1
TMSCs-PEG3-FTH1 and TMSCs-CMV-FTH1 cells(
P
<
0.05). Prussian blue staining and transmission electron microscopy identified the presence of iron particles in MSCs-CMV-FTH1
TMSCs-PEG3-FTH1 and TMSCs-CMV-FTH1 cells
but not in MSCs
MSCs-PEG3-FTH1 cells or TMSCs.
In vitro
MRI showed obviously decreased T
2
signal in TMSCs-PEG3-FTH1 cells as compared with MSCs-PEG3-FTH1 cells.
Conclusion
2
PEG3 promoter can drive the specific expression of FTH1 that allows MRI detection in rat MSCs after malignant transformation.
关键词
Keywords
references
LITWINOWICZ R, KAPELAK B, SADOWSKI J, et al. The use of stem cells in ischemic heart disease treatment[J]. Kardiochir Torakochirurgia Pol, 2018, 15(3): 196-199. DOI: 10.5114/kitp.2018.78446.
BŁOGOWSKI W, BODNARCZUK T, STARZYÑSKA T. Concise review: pancreatic cancer and bone marrow-derived stem cells[J]. Stem Cells Transl Med, 2016, 5(7): 938-945. DOI: 10.5966/sctm.2015-0291.
KATSUKAWA M, NAKAJIMA Y, FUKUMOTO A, et al. Fail-safe therapy by gamma-ray irradiation against tumor formation by human-induced pluripotent stem cell-derived neural progenitors[J]. Stem Cells Dev, 2016, 25(11): 815-825. DOI: 10.1089/scd.2015.0394.
CLÉMENT F, GROCKOWIAK E, ZYLBERSZTEJN F, et al. Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence[J]. Stem Cell Invest, 2017, 4: 67. DOI: 10.21037/sci.2017.07.03.
SU Z Z, SARKAR D, EMDAD L, et al. Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter[J]. Proc Natl Acad Sci U S A, 2005, 102(4): 1059-1064. DOI: 10.1073/pnas.0409141102.
LIU H J, HU R Y, DAI W J, et al. Culture and identification of bone marrow mesenchymal stem cells from enhanced green fluorescent protein-transgenic rats[J]. Acta Acad Med Sin, 2016, 38(1): 9-15. DOI: 10.3881/j.issn.1000-503X.2016.01.002.
LI X Y, ZHANG Y, QI G X. Evaluation of isolation methods and culture conditions for rat bone marrow mesenchymal stem cells[J]. Cytotechnology, 2013, 65(3): 323-334. DOI: 10.1007/s10616-012-9497-3.
LIAO Y F, CAI J H, ZHONG Y, et al. Specific expression and in vitro magnetic resonance imaging of NSE-promoter in initiating FTH1 gene during neural differentiation of bone marrow mesenchymal stem cells[J ] .J Third Mil Med Univ, 2018, 40(13): 1171-1178. DOI: 10.16016/j.1000-5404.201712135.
BHANG H E, GABRIELSON K L, LATERRA J, et al. Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression[J]. Nat Med, 2011, 17(1): 123-129. DOI: 10.1038/nm.2269.
CHAN I, LEBEDEVA I V, SU Z Z, et al. Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression[J]. J Cell Physiol, 2008, 215(2): 401-409. DOI: 10.1002/jcp.21320.
SONG K, HUANG M Q, SHI Q, et al. Cultivation and identification of rat bone marrow-derived mesenchymal stem cells[J]. Mol Med Rep, 2014, 10(2): 755-760. DOI: 10.3892/mmr.2014.2264.
TAN B, SHEN L J, YANG K, et al. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway[J]. Biochem Biophys Res Commun, 2018, 495(1): 78-85. DOI: 10.1016/j.bbrc.2017.10.071.
CARETTI V, SEWING A C, LAGERWEIJ T, et al. Human pontine glioma cells can induce murine tumors[J]. Acta Neuropathol, 2014, 127(6): 897-909. DOI: 10.1007/s00401-014-1272-4.
KONG X Y, GUAN J, MA W B, et al. CD34 over-expression is associated with gliomas' higher WHO grade[J]. Medicine (Baltimore), 2016, 95(7): e2830. DOI: 10.1097/MD.0000000000002830.
[Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34 + cells in HIV-1 infection: Erratum[J ] . AIDS, 2018, 32(18): 2857-2858. DOI: 10.1097/01.aids.0000547984.16868.93 http://dx.doi.org/10.1097/01.aids.0000547984.16868.93 ..
MILDMAY-WHITE A, KHAN W. Cell surface markers on adipose-derived stem cells: a systematic review[J]. Curr Stem Cell Res Ther, 2017, 12(6): 484-492. DOI: 10.2174/1574888X11666160429122133.
KOBOLAK J, DINNYES A, MEMIC A, et al. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche[J]. Methods, 2016, 99: 62-68. DOI: 10.1016/j.ymeth.2015.09.016.
AVRIL T, ETCHEVERRY A, PINEAU R, et al. CD90 expression controls migration and predicts dasatinib response in glioblastoma[J]. Clin Cancer Res, 2017, 23(23): 7360-7374. DOI: 10.1158/1078-0432.CCR-17-1549.
SUKOWATI C H, ANFUSO B, TORRE G, et al. The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study[J ] . PLoS ONE, 2013, 8(10): e76830. DOI: 10.1371/journal.pone.0076830..
MORAES D A, SIBOV T T, PAVON L F, et al. A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells[J]. Stem Cell Res Ther, 2016, 7(1): 97. DOI: 10.1186/s13287-016-0359-3.
Specific expression and in vitro magnetic resonance imaging of NSE-promoter in initiating FTH1 gene during neural differentiation of bone marrow mesenchymal stem cells
Value of imaging to evaluate experimental effects of mesenchymal stem cells therapy for ischemic stroke rats
Differential diagnostic efficacy of tumor vascular habitats based on DSC-PWI between glioblastoma and solitary metastatic brain tumors
Quantitative assessment of early lumbar disc degeneration in patients with low back pain by T1rho magnetic resonance imaging
Value of DCE-MRI parameters for short-term prognosis of pharyngeal cancer after postoperative radiotherapy
Related Author
Yifan LIAO
Jinhua CAI
Yi ZHONG
Xiaoya HE
Yong QIN
Jun SUN
马秀华
吕富荣
Related Institution
Department of Radiology, Key Laboratory of Child Development and Disorders Cofounded by Chongqing and Ministry of Education, Chongqing Key Laboratory of Pediatrics, Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Children's Hospital of Chongqing Medical University
Department of Radiology, Mianyang Central Hospital
Department of Radiology
Chongqing Clinical Research Centre of Imaging and Nuclear Medicine
Department of Pathology, Daping Hospital, Army Medical University